Immunomedics (IMMU) News Today

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis

Source

Source	Headline
	The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts markets.businessinsider.com - April 19 at 3:46 PM
	What the Options Market Tells Us About Gilead Sciences benzinga.com - April 18 at 1:36 PM
	NorthStar Appoints Peter Pfreundschuh to Board of Managers finance.yahoo.com - April 15 at 9:28 AM
	Gilead bets on ‘trispecifics’ in latest cancer drug deal finance.yahoo.com - March 6 at 6:16 PM
	Abingworth invests in Trodelvy development in deal with Gilead finance.yahoo.com - February 29 at 2:43 PM
	Gilead (GILD) to Buy CBAY for $4.3B, Add PBC Drug to Pipeline msn.com - February 13 at 12:40 PM
	Gilead Sciences, Inc.: Gilead: Maintaining Our $97 Fair Value Estimate as CymaBay Acquisition Looks Like a Good Fit finance.yahoo.com - February 12 at 9:16 PM
	Gilead to buy CymaBay in $4.3B deal for liver disease drug finance.yahoo.com - February 12 at 4:16 PM
	Gilead Sciences, Inc.: Gilead Earnings: Maintaining $97 Fair Value Estimate as HIV and Oncology Catalysts Approach finance.yahoo.com - February 7 at 8:49 PM
	Gilead Sciences, Inc.: Gilead: Trodelvy Lung Cancer Data Disappoints, but No Changes to Our Fair Value Estimate finance.yahoo.com - January 22 at 9:17 PM
	Arvinas Appoints Jared Freedberg as General Counsel finance.yahoo.com - January 16 at 5:46 PM
	NeuroTrauma Sciences Appoints William Fricker, CPA, MBA, as Chief Financial Officer finance.yahoo.com - January 9 at 12:05 PM
	Gilead Sciences's Options: A Look at What the Big Money is Thinking benzinga.com - November 15 at 2:32 PM
	A Closer Look at Gilead Sciences's Options Market Dynamics benzinga.com - November 9 at 6:37 PM
	Gilead Sciences, Inc.: Gilead Earnings: Maintaining Our $97 FVE Following In-Line HIV and Oncology Performance finance.yahoo.com - November 8 at 3:12 PM
	Daily Digest: Slack CEO departs; Big East Bay battery factory opens bizjournals.com - November 6 at 2:36 PM
	Gilead sues former CFO of Immunomedics to claw back $4 million bizjournals.com - November 6 at 2:36 PM
	Spate of Deal News Juices Start of This Week's Trading realmoney.thestreet.com - October 29 at 3:42 PM
	Unraveling Gilead Sciences Inc's Dividend Performance and Sustainability finance.yahoo.com - September 14 at 7:53 AM
	Antibody Drug Conjugate (ADC) Markets, 2035 uk.finance.yahoo.com - August 24 at 7:26 AM
	8 Undervalued Quality Healthcare Stocks morningstar.com - August 13 at 3:07 AM
	Gilead Sciences, Inc.: Gilead's HIV Dominance and Growing Oncology Portfolio Support a Wide Moat finance.yahoo.com - August 4 at 7:33 PM
	Immunomedics, Seattle Genetics Lead Biotech Movers on Deal News thestreet.com - July 19 at 6:46 PM
	Looking For Attractive Uncorrelated Returns in a Highly Uncertain Market? Consider Merger Arbitrage finance.yahoo.com - July 11 at 1:04 PM
	The global Cell therapy Processing market Size during the period of 2023 to 2030 is expected grow at CAGR of 9.1% marketwatch.com - June 22 at 7:49 PM
	European shares slip on US debt ceiling concerns msn.com - May 18 at 8:31 PM
	ASIA Japan leads the way, China feels the heat reuters.com - May 17 at 6:31 PM
	Former Immunomedics CFO pleads guilty to insider trading msn.com - May 17 at 6:31 PM
	Next Generation Antibody Therapeutics Market Size: Growth Dynamics from 2023 to 2031 marketwatch.com - May 17 at 1:30 PM
	Future of Antibody Drug Conjugate Market 2023: Active Key Players and Emerging Trends in Industry till 2030 marketwatch.com - May 16 at 5:28 PM
	2030, Immunocytokines Market Research marketwatch.com - May 15 at 5:00 PM
	Chemotherapy Market Future Investments and Forecast Till 2030 marketwatch.com - May 11 at 11:34 PM
	Gilead Sciences, Inc.: Gilead Earnings: HIV and Oncology Growth Remain Solid, Maintaining Our FVE Despite Higher Opex finance.yahoo.com - April 29 at 8:29 AM
	Antibody-Drug Conjugates (ADCs) Market Size Worth USD 20.01 Billion in 2028 – Emergen Research markets.businessinsider.com - April 28 at 10:43 AM
	Radioimmunotherapy Treatment Market Size by 2031 marketwatch.com - April 28 at 10:43 AM
	Immunocytokines Market Demand by 2031 marketwatch.com - April 22 at 8:55 AM
	2023-2030 Antibody Drug Conjugate Market Growth Developments with Latest Updates marketwatch.com - April 21 at 4:55 AM
	Navigating the Burkitt Lymphoma Treatment Market Growth Outlook by market Trends and market size Using a 11.5% CAGR from 2023 - 2030 marketwatch.com - April 19 at 8:56 PM
	Global Celiac Drugs Market Size To Grow On The Basis Of Refined Innovation From 2023-2030 By VMReports marketwatch.com - March 26 at 8:26 AM
	Global Cell therapy Processing Market Analysis By Type Technology End-Use By Region By Country and Forecast 2023 to 2030 By VMReports marketwatch.com - March 4 at 3:49 PM
	Celiac Disease Drugs Market [Latest Report] Review Report 2023 Alongside Insights, Figures till 2028 marketwatch.com - March 3 at 7:04 PM
	Cowden Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023 - 2030 marketwatch.com - March 2 at 8:31 AM
	Bispecific Antibody Market Insights-Industry changing aspects, New Technologies and Forecast to 2027 marketwatch.com - February 12 at 5:37 PM
	Radioimmunotherapy Market : Reliable Business Data Analysis and Forecast by 2028 with Top Countries Data marketwatch.com - January 31 at 7:08 AM
	Antibody Drug Conjugate Market Size and Share 2023 \| Register to Grow by Highest CAGR, and Revenue by 2028 with Latest Opportunities and Trends marketwatch.com - January 28 at 10:28 AM
	This report on Metastatic Prostate Cancer Treatment research analysts highlights the existing knowledge on this market size. marketwatch.com - December 18 at 8:18 AM
	Antibody Drug Conjugates (ADCs) Market 2023 : Production Capacity, Restring Drivers, Size and Landscape Outlook 2028 marketwatch.com - December 15 at 9:40 AM
	Celiac Disease Market 2023 : Growth Statistics, Revenue Estimates, Emerging Trends, Top Leading Players with Strategies and Forecast 2028 marketwatch.com - December 12 at 2:51 AM
	Peak Gilead seekingalpha.com - November 1 at 1:12 PM
	Biotechs look to sell royalties to raise cash in a tough market ft.com - November 1 at 1:12 PM

Get Immunomedics News Delivered to You Automatically

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

IMMU Media Mentions By Week

IMMU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMMU
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

IMMU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMMU Articles
This Week
▼
3

0
▲
IMMU Articles
Average Week

Get Immunomedics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:IMMU) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Immunomedics (IMMU) News Today

IMMU Media Mentions By Week

IMMU Media Sentiment

IMMU News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info